Introduction
Dravet syndrome (or severe myoclonic epilepsy in infancy, SMEI, MIM# 607208) is an intractable epileptic syndrome characterized by various types of seizures beginning in the first year of life, with prolonged seizures that are often provoked by fever (Dravet et al., 2005) . De novo mutations of SCN1A, which encodes the Na v 1.1 neuronal voltage-gated sodium channel, are detected in approximately 70 to 80% of subjects with Dravet syndrome. SCN1A mutations have therefore been considered to be the major cause of this syndrome (Claes et al., 2001; Depienne et al., 2009; Ohmori et al., 2002) . However, several studies have suggested that environmental factors and genetic modifiers may influence the clinical phenotype of Dravet syndrome. Subjects with the same SCN1A mutation often show different severities of epilepsy (Guerrini et al., 2010; Suls et al., 2010) , and approximately 50% of subjects with Dravet syndrome have a family history of convulsive disorders, including febrile seizures and benign epilepsy (Dravet et al., 2005; Hattori et al., 2008) . Moreover, genetic background influences the severity of epilepsy in a SMEI mouse model harboring a truncated SCN1A mutation (Yu et al., 2006) . The 129/SvJ mouse strain exhibited a decreased incidence of spontaneous seizures and survived longer compared to C57BL/6J mice, indicating that genetic background affects the Scn1a knockout (KO) mouse phenotype.
Supporting evidence for a multifactorial etiology of Dravet syndrome has been reported (Singh et al., 2009) . Singh et al. demonstrated that patients with SCN9A variants develop febrile seizures, and 6 of 109 subjects with Dravet syndrome had missense variants of SCN9A, in addition to de novo SCN1A mutations. These SCN9A missense variants possibly contribute to the clinical severity of Dravet syndrome.
A missense mutation of CACNB4, which encodes the β4 subunit of the voltage-dependent calcium channel, was detected in one person out of the 38 subjects with Dravet syndrome (Ohmori et al., 2008) . This person had a de novo SCN1A nonsense mutation and a CACNB4 missense mutation (R468Q), which was inherited from his father who had a history of a single febrile seizure. A previous electrophysiological study of heterologously expressed CACNB4-R468Q revealed increased Ca v 2.1 (P/Q type) voltage-gated calcium channel current density. However, the detection rate for CACNB4 variants and mutations was low, so we decided to perform mutational analysis of other genes. 
